학술논문

A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial
Document Type
Article
Source
In: Transplantation and Cellular Therapy. (Transplantation and Cellular Therapy, June 2023, 29(6):358.e1-358.e7)
Subject
Language
English
ISSN
26666367